• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Nipah virus threat in India: Epidemiological trends, risk drivers, and lessons for pandemic preparedness

Shiloh

Editor, Senior Moderator
Source: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014226


The Nipah virus threat in India: Epidemiological trends, risk drivers, and lessons for pandemic preparedness
Apoorva, Sunit K. Singh
Published: May 20, 2026
https://doi.org/10.1371/journal.ppat.1014226

Abstract

Nipah virus (NiV), a WHO-priority zoonotic pathogen, poses a recurrent public health threat in India. Since its initial detection in 2001, India has encountered multiple NiV spillover events, including repeated outbreaks in Kerala and recent cases reported in West Bengal in 2026. Although the pig-amplified epidemic in Malaysia (1998–1999) and the seasonal outbreaks associated with NiV-contaminated date palm sap consumption in Bangladesh are extensively documented, India represents a unique and relatively understudied epidemiological setting. NiV outbreaks in India are primarily linked to the NiV-Bangladesh clade and are marked by direct spillover transmission from bats to humans, elevated case-fatality rates, clustered emergence, and effective household/nosocomial transmission without an intermediate amplifying host. Spillover risk is influenced by region-specific ecological and socio-economic factors, including contamination of peri-domestic fruit, proximity of bat roosts to human settlements, deforestation, and urban expansion. To date, no treatment or vaccine is available for humans or animals. This review synthesizes evidence from India spanning 2001 to 2026. It integrates aspects of epidemiology, bat reservoir ecology, viral genomics, clinical manifestations, surveillance experiences, and health system responses, while contrasting India’s transmission dynamics with those observed in Malaysia and Bangladesh. Furthermore, we explore India’s current preparedness and response strategies, highlighting the critical shift from reactive outbreak control to a proactive, integrated “One Health” framework. The strategy to strengthen integrated surveillance, contact tracing, isolation, and quarantine of suspected and confirmed cases, advance India-developed vaccines and therapeutics, and address the root ecological drivers of zoonotic emergence is essential for national and global health security...




​​​
 
Back
Top